LivsMed Selects AcuityMD to Accelerate Adoption of ArtiSential Instruments for Optimal Results at Less Cost than Robotics
October 31, 2023
AcuityMD’s platform helps emerging MedTech company solve commercialization challenges
October 31, 2023
AcuityMD’s platform helps emerging MedTech company solve commercialization challenges
October 10, 2023
AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced that Intellijoint Surgical, developer of surgical planning and navigation solutions for total hip and knee joint replacements, will leverage its platform to identify new business prospects, manage pipeline, and scale operations. Intellijoint’s easy-to-use devices are used by leading orthopedic surgeons globally.
September 26, 2023
AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced the launch of Pipeline, a new module that enables sales representatives to execute on prospects throughout the sales lifecycle, track progress, forecast accurately, and ultimately improve business planning to grow revenue.
September 12, 2023
BOSTON — September 12, 2023 —AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals (HCPs).
August 15, 2023
AcuityMD’s data-driven commercial platform has helped device innovators identify more than 60,000 untapped healthcare professionals and over $6 billion in opportunity value.
May 3, 2023
FEMSelect, an Israeli-based MedTech startup, partners with AcuityMD to accelerate identification and engagement of U.S. physicians treating pelvic floor disorders (PFD).
April 4, 2023
AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology
December 6, 2022
New data-driven, commercial platform for medical technology companies fills market need in a fast-growing industry, forecasted CAGR of 5.5% through 2029
October 20, 2022
AcuityMD accelerates widespread market access to novel opioid withdrawal treatment device, currently in use across 24 U.S. rehabilitation facilities
May 12, 2022
By Michael Monovoukas, co-founder & CEO, AcuityMD